OptiBiotix Health (LON:OPTI) Stock Falls 10.6% – Time to Sell?

Shares of OptiBiotix Health Plc (LON:OPTI) dropped 10.6% on Wednesday. The company traded as low as GBX 4.55 and last traded at GBX 4.56. 537,026 shares changed hands during trading, an increase of 72% from the average daily volume of 311,584 shares. The stock had previously closed at GBX 5.10.

OptiBiotix Health Stock Performance

The business has a fifty day simple moving average of GBX 5.82 and a 200-day simple moving average of GBX 5.89. The firm has a market cap of £4.71 million, a price-to-earnings ratio of -1.08 and a beta of 1.82.

OptiBiotix Health (LON:OPTI) last announced its quarterly earnings results on Thursday, September 17th. The company reported GBX (1.52) EPS for the quarter. OptiBiotix Health had a negative net margin of 332.69% and a negative return on equity of 77.85%.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.